Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Invested Capital (2021 - 2022)

Historic Return on Invested Capital for Ovid Therapeutics (OVID) over the last 2 years, with Q4 2022 value amounting to 0.41%.

  • Ovid Therapeutics' Return on Invested Capital fell 10600.0% to 0.41% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.41%, marking a year-over-year decrease of 10600.0%. This contributed to the annual value of 1.09% for FY2021, which is N/A changed from last year.
  • Per Ovid Therapeutics' latest filing, its Return on Invested Capital stood at 0.41% for Q4 2022, which was down 10600.0% from 0.47% recorded in Q3 2022.
  • Over the past 5 years, Ovid Therapeutics' Return on Invested Capital peaked at 0.65% during Q4 2021, and registered a low of 0.47% during Q3 2022.